Germany Infectious Disease Industry Outlook 2022 - 2026

Key Market Indicators

By 2026, German influenza deaths are expected to reach 2,870. This is a 4.1% growth rate compared to 2021, when 2,210 deaths were recorded. Since 1995, German demand for influenza deaths has jumped 51.5% year on year. In 2021, Germany was the third highest ranked country for influenza deaths. Japan had the highest number of deaths with 2,210, and Canada was fourth with 2,210.

Germany Infectious Disease Market Data and Forecasts

Improve your Knowledge with the latest Indicators and Trends

• Viral Infections: Unmasking the Developing Trends and Opportunities in HHV-4 and HHV-5 Pipelines

  The landscape of Herpesviruses (HHV) 4 and 5 infections, widely known as Epstein-Barr Virus (EBV) and Cytomegalovirus (CMV) respectively, has experienced significant changes in the recent past. Challenges in developing effective treatments have led to a heightened focus on research, with several new drugs in the pipeline. Current attention has...

  Discover more insights

• Pharmaceutics Impact: Delving Into the Global Tuberculosis Treatment Drugs Market Landscape

  Growing demands for more effective treatments in response to the expanding global tuberculosis (TB) burden have marked the present landscape of the TB drugs market. Constant advancements in research and development have led to the introduction of novel products, while the presence of robust distribution networks facilitates reach to global...

  Discover more insights

• Influenza A Virus: Unpacking Subtype Trends in Pipeline Reviews

  The Influenza A virus market segment remains essential, due to the recurrent need for effective vaccines and treatments. The industry is marked by iterative advancements, where prevailing therapeutic strategies are often displaced by newer ones. This is necessitated by the virus's propensity for mutation, a factor that underlines the importance...

  Discover more insights

• Infectious Disease Market: Analysis, Emerging Technologies, and Opportunities for Suppliers

  In terms of diagnostic technologies for infectious diseases, the landscape presents as ever-evolving. Suppliers are constantly engaged in the development and refinement of detection techniques, targeting early identification of a broad spectrum of infections. These innovations play a vital role in patient treatment and long-term disease management within all healthcare...

  Discover more insights

• Infectious Disease Market: Analyzing Opportunities and Competitive Landscape in Technology Trends

  The infectious disease market is evolving in response to ongoing public health challenges, such as the COVID-19 pandemic. This market features various sectors focusing on the development and distribution of vaccines, antivirals, antibiotics, and diagnostic tests. Market growth is primarily driven by factors such as increased incidences of infectious diseases,...

  Discover more insights

• 1
• 2